Prime Medicine, Inc. Profile Avatar - Palmy Investing

Prime Medicine, Inc.

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase…

Biotechnology
US, Cambridge [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Prime Medicine, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Prime Medicine, Inc. can't present revenue by segment

End of PRME's Analysis
CIK: 1894562 CUSIP: 74168J101 ISIN: US74168J1016 LEI: - UEI: -
Secondary Listings
PRME has no secondary listings inside our databases.